{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:57:40Z","timestamp":1780495060801,"version":"3.54.1"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1097\/inf.0000000000005114","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T05:00:45Z","timestamp":1766034045000},"page":"e165-e168","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Eye Spy With My Little Eye the Three T\u2019s: Ocular Manifestations of Toxocara, Toxoplasma and Tuberculosis in Children"],"prefix":"10.1097","volume":"45","author":[{"given":"Lucy","family":"Jefferson","sequence":"first","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Great Ormond Street Hospital for Children NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Petrushkin","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Moorfields Eye Hospital"},{"name":"Department of Ophthalmology, Great Ormond Street Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garth","family":"Dixon","sequence":"additional","affiliation":[{"name":"Department of Paediatric Microbiology, Great Ormond Street Hospital for Children NHS Foundation Trust"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3658-7635","authenticated-orcid":false,"given":"Seilesh","family":"Kadambari","sequence":"additional","affiliation":[{"name":"Department of Paediatric Infectious Diseases, Great Ormond Street Hospital for Children NHS Foundation Trust"},{"name":"Infection, Immunity and Inflammation Department, University College London, Great Ormond Street Institute of Child Health, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/bs.apar.2020.01.011","article-title":"Global and regional seroprevalence estimates for human toxocariasis: a call for action.","volume":"109","author":"Ma","year":"2020","journal-title":"Adv Parasitol"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/zph.12259","article-title":"Epidemiology of toxocariasis in England and Wales.","volume":"63","author":"Halsby","year":"2016","journal-title":"Zoonoses Public Health"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"e90203","DOI":"10.1371\/journal.pone.0090203","article-title":"Toxoplasmosis\u2014a global threat. correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries.","volume":"9","author":"Flegr","year":"2014","journal-title":"PLoS One"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1017\/S095026881300246X","article-title":"Enhanced surveillance for toxoplasmosis in England and Wales, 2008-2012.","volume":"142","author":"Halsby","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4269\/ajtmh.2010.09-0664","article-title":"Annual burden of ocular toxoplasmosis in the US.","volume":"82","author":"Jones","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/pathogens13100898","article-title":"Ocular toxoplasmosis: advances in toxoplasma gondii biology, clinical manifestations, diagnostics, and therapy.","volume":"13","author":"Miyagaki","year":"2024","journal-title":"Pathogens"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1038\/s41433-019-0748-9","article-title":"Presumed ocular tuberculosis in the United Kingdom: a British ophthalmological surveillance unit (BOSU) study.","volume":"34","author":"Shirley","year":"2020","journal-title":"Eye"},{"key":"R9-20260410","first-page":"237","article-title":"Ocular tuberculosis\u2014a clinical conundrum.","volume":"24","author":"Lee","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005792-199701000-00005","article-title":"Ocular tuberculosis. A prospective study in a general hospital.","volume":"76","author":"Bouza","year":"1997","journal-title":"Medicine (Baltim)"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1001\/jamaophthalmol.2013.71","article-title":"Mycobacterial ocular inflammation: delay in diagnosis and other factors impacting morbidity.","volume":"131","author":"Patel","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"e001225","DOI":"10.1136\/bmjresp-2022-001225","article-title":"BTS clinical statement for the diagnosis and management of ocular tuberculosis.","volume":"9","author":"Kon","year":"2022","journal-title":"BMJ Open Respir Res"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1080\/09273948.2020.1781197","article-title":"The collaborative ocular tuberculosis study (COTS)-1: a multinational descriptive review of tubercular uveitis in paediatric population.","volume":"28","author":"Testi","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/09273948.2019.1646774","article-title":"Tubercular uveitis: nuggets from collaborative ocular tuberculosis study (COTS)-1.","volume":"28","author":"Testi","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/S0022149X18000895","article-title":"New insight into the diagnostic cut-off value of serum anti-Toxocara IgG for ocular toxocariasis in uveitis patients.","volume":"94","author":"Abd El-Aal","year":"2018","journal-title":"J Helminthol"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ajo.2007.09.020","article-title":"Diagnosis of ocular toxocariasis by establishing intraocular antibody production.","volume":"145","author":"de Visser","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/JCM.01793-14","article-title":"PCR-based detection of toxoplasma gondii DNA in blood and ocular samples for diagnosis of ocular toxoplasmosis.","volume":"52","author":"Bourdin","year":"2014","journal-title":"J Clin Microbiol"},{"key":"R18-20260410","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.diagmicrobio.2015.09.009","article-title":"Serological diagnosis of Toxoplasma gondii infection: recommendations from the French national reference center for toxoplasmosis.","volume":"84","author":"Villard","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"R19-20260410","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s12886-017-0597-x","article-title":"What does IGRA testing add to the diagnosis of ocular tuberculosis? A Bayesian latent class analysis.","volume":"17","author":"Agrawal","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"R20-20260410","doi-asserted-by":"crossref","first-page":"808","DOI":"10.5301\/ejo.5000121","article-title":"Clinical application of an in-house ELISPOT assay in patients with suspicious tuberculous uveitis and no signs of active tuberculosis.","volume":"22","author":"Modorati","year":"2012","journal-title":"Eur J Ophthalmol"},{"key":"R21-20260410","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1080\/09273948.2023.2284990","article-title":"Pediatric posterior infectious uveitis.","volume":"31","author":"Curi","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"R22-20260410","doi-asserted-by":"crossref","first-page":"ofae476","DOI":"10.1093\/ofid\/ofae476","article-title":"Epidemiology and clinical characteristics of ocular tuberculosis in the United States, 1993-2019.","volume":"11","author":"Filardo","year":"2024","journal-title":"Open Forum Infect Dis"},{"key":"R23-20260410","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ijmmb.2021.12.019","article-title":"Detection of viable Mycobacterium tuberculosis in ocular fluids using mRNA-based multiplex polymerase chain reaction.","volume":"40","author":"Sharma","year":"2022","journal-title":"Indian J Med Microbiol"},{"key":"R24-20260410","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/bjo-2022-322244","article-title":"Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis.","volume":"108","author":"Sun","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"R25-20260410","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/microorganisms10020241","article-title":"Therapy and prevention for human toxocariasis.","volume":"10","author":"Magnaval","year":"2022","journal-title":"Microorganisms"},{"key":"R26-20260410","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/108076801750295317","article-title":"Treatment of ocular toxocariasis with albendazole.","volume":"17","author":"Barisani-Asenbauer","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"R27-20260410","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ophtha.2020.06.052","article-title":"Collaborative ocular tuberculosis study consensus guidelines on the management of tubercular uveitis\u2014report 2: guidelines for initiating antitubercular therapy in anterior uveitis, intermediate uveitis, panuveitis, and retinal vasculitis.","volume":"128","author":"Agrawal","year":"2021","journal-title":"Ophthalmology"},{"key":"R28-20260410","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.survophthal.2022.10.001","article-title":"Anti-tubercular therapy in the treatment of tubercular uveitis: a systematic review and meta-analysis.","volume":"68","author":"Betzler","year":"2023","journal-title":"Surv Ophthalmol"},{"key":"R29-20260410","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.oret.2018.05.002","article-title":"Effect of adjunctive pars plana vitrectomy on focal posterior segment inflammation: a case-control study in tuberculosis-associated uveitis.","volume":"2","author":"Kaza","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R30-20260410","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1080\/09273948.2017.1296580","article-title":"Visual morbidity and ocular complications in presumed intraocular tuberculosis: an analysis of 354 cases from a non-endemic population.","volume":"26","author":"Gunasekeran","year":"2018","journal-title":"Ocul Immunol Inflamm"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:01:17Z","timestamp":1775793677000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005114","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]}}}